| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |